Xiaojie Bian

1.3k total citations
24 papers, 573 citations indexed

About

Xiaojie Bian is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xiaojie Bian has authored 24 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Xiaojie Bian's work include Cancer-related molecular mechanisms research (6 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Xiaojie Bian is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Xiaojie Bian collaborates with scholars based in China, United States and Finland. Xiaojie Bian's co-authors include Jianhua Wang, Leilei Du, Tianqi Wu, Mengfei Yao, Shancheng Ren, Yu‐Tian Xiao, Dingwei Ye, Min Jiang, Yijun Shen and Zeyi Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Molecular Cancer.

In The Last Decade

Xiaojie Bian

21 papers receiving 573 citations

Peers

Xiaojie Bian
Jinsong Wang China
Haoyue Hu China
Satoe Fujiwara Japan
Songming Ding China
Xiaojian Ni China
Patrick Tassone United States
Wenqing Feng China
Shu‐Fang Jian Taiwan
Wei Cang China
Hidetaka Sugihara Japan
Jinsong Wang China
Xiaojie Bian
Citations per year, relative to Xiaojie Bian Xiaojie Bian (= 1×) peers Jinsong Wang

Countries citing papers authored by Xiaojie Bian

Since Specialization
Citations

This map shows the geographic impact of Xiaojie Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Bian more than expected).

Fields of papers citing papers by Xiaojie Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Bian. The network helps show where Xiaojie Bian may publish in the future.

Co-authorship network of co-authors of Xiaojie Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Bian. A scholar is included among the top collaborators of Xiaojie Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Bian. Xiaojie Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Wei, Hualei Gan, Xiaomeng Li, et al.. (2025). Neoadjuvant fuzuloparib combined with abiraterone for localized high-risk prostate cancer (FAST-PC): A single-arm phase 2 study. Cell Reports Medicine. 6(3). 102018–102018. 3 indexed citations
2.
Yao, Mengfei, Xingming Zhang, Tianqi Wu, et al.. (2025). Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer. Cell Death and Disease. 16(1). 116–116. 1 indexed citations
3.
4.
5.
Bian, Xiaojie, Wenfeng Wang, Mierxiati Abudurexiti, et al.. (2024). Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity. Advanced Science. 11(18). e2305724–e2305724. 36 indexed citations
6.
Li, Junhong, Xingming Zhang, Xiaojie Bian, et al.. (2023). Relationships of body composition and adipocytokines with outcomes in metastatic castration-resistant prostate cancer patients receiving docetaxel chemotherapy. Asian Journal of Andrology. 25(4). 520–527. 3 indexed citations
7.
Su, Yang, et al.. (2022). Community pandemic prevention and control measures and their influence on citizen satisfaction during the COVID-19 pandemic in China. International Journal of Disaster Risk Reduction. 85. 103494–103494. 3 indexed citations
8.
Wu, Tianqi, Wenfeng Wang, Guohai Shi, et al.. (2022). Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death and Disease. 13(7). 624–624. 38 indexed citations
9.
Ye, Dingwei, Xiaojie Bian, Bin Wu, et al.. (2022). Phase II therapeutic equivalence study of Abiraterone Acetate Tablets (I) vs. ZYTIGA® in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 40(16_suppl). e17040–e17040.
10.
Wu, Tianqi, Wenfeng Wang, Mengfei Yao, et al.. (2021). Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer. Translational Andrology and Urology. 10(7). 3056–3068. 4 indexed citations
11.
Yao, Mengfei, Xiaolei Shi, Yue Li, et al.. (2020). LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Cell Death and Disease. 11(8). 638–638. 29 indexed citations
12.
Bian, Xiaojie, Yu‐Tian Xiao, Tianqi Wu, et al.. (2019). Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression. Molecular Cancer. 18(1). 50–50. 120 indexed citations
13.
Bian, Xiaojie, et al.. (2018). Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer. Medicine. 97(22). e10988–e10988. 26 indexed citations
14.
Xu, Ning, Shaomu Chen, Yufeng Liu, et al.. (2018). Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells. Cellular Physiology and Biochemistry. 48(5). 2046–2060. 62 indexed citations
15.
Xie, Jing, Yufeng Wu, Xiaojie Bian, et al.. (2018). Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.. PubMed. 11(7). 3703–3707. 6 indexed citations
16.
Wu, Xiao Yu, Mengyao Wu, Min Jiang, et al.. (2017). TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International. 17(1). 13–13. 61 indexed citations
17.
18.
Bian, Xiaojie, Yijun Shen, Guiming Zhang, et al.. (2015). Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer. PLoS ONE. 10(3). e0120159–e0120159. 19 indexed citations
19.
Zhu, Yiping, Xiaojie Bian, Dingwei Ye, et al.. (2014). Long noncoding RNA expression signatures of bladder cancer revealed by microarray. Oncology Letters. 7(4). 1197–1202. 40 indexed citations
20.
Zhu, Yiping, Xiaojie Bian, Dingwei Ye, et al.. (2013). Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits proliferation and induces apoptosis in a caspase-dependent manner in human bladder cancer cell lines. Oncology Letters. 5(4). 1357–1362. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinsong Wang Breakdown of academic impact, for papers by Haoyue Hu Breakdown of academic impact, for papers by Satoe Fujiwara Breakdown of academic impact, for papers by Songming Ding Breakdown of academic impact, for papers by Xiaojian Ni Breakdown of academic impact, for papers by Patrick Tassone Breakdown of academic impact, for papers by Wenqing Feng Breakdown of academic impact, for papers by Shu‐Fang Jian Breakdown of academic impact, for papers by Wei Cang Breakdown of academic impact, for papers by Hidetaka Sugihara
Rankless by CCL
2026